title: Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic).
abstract: There have been major advances in our understanding of the multiple interactions between malignant cells and the innate and adaptive immune system. While the attention of immunologists has hitherto focused on solid tumors, the specific immunobiology of acute leukemias is now becoming defined. These discoveries have pointed the way to immune interventions building on the established graft-versus-leukemia (GVL) effect from hematopoietic stem-cell transplant (HSCT) and extending immunotherapy beyond HSCT to individuals with acute leukemia with a diversity of immune manipulations early in the course of the leukemia. At present, clinical results are in their infancy. In the coming years larger studies will better define the place of immunotherapy in the management of acute leukemias and lead to treatment approaches that combine conventional chemotherapy, immunotherapy and HSCT to achieve durable cures.
authors.affiliation: Hematology Branch, National Heart, Lung, and Blood Institute, US National Institutes of Health, Bethesda, MD, USA.
authors.forename: Kazusa
authors.initials: K
authors.lastname: Ishii
authors.affiliation: Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Austin J
authors.initials: AJ
authors.lastname: Barrett
keywords: immune-editing; immunotherapy; leukemia
references.citation: Leukemia. 2014 May;28(5):1167-70
references.pmid: 24472813
references.citation: Br J Cancer. 2003 Oct 6;89(7):1221-7
references.pmid: 14520450
references.citation: Blood. 2007 Nov 1;110(9):3192-201
references.pmid: 17616639
references.citation: Am J Transplant. 2007 Apr;7(4):941-8
references.pmid: 17331115
references.citation: Leukemia. 2013 Jun;27(6):1403-7
references.pmid: 23354011
references.citation: J Immunol. 1999 Oct 15;163(8):4182-91
references.pmid: 10510354
references.citation: Semin Immunol. 2010 Jun;22(3):162-72
references.pmid: 20537908
references.citation: Haematologica. 2012 Mar;97(3):393-401
references.pmid: 22058219
references.citation: Clin Cancer Res. 2013 Sep 15;19(18):5079-91
references.pmid: 23838315
references.citation: Br J Haematol. 2010 Jul;150(1):72-82
references.pmid: 20456355
references.citation: Nat Immunol. 2002 Nov;3(11):999-1005
references.pmid: 12407407
references.citation: Blood. 2011 Apr 28;117(17):4501-10
references.pmid: 21385853
references.citation: Cancer Res. 2006 Jan 15;66(2):1123-31
references.pmid: 16424049
references.citation: Cancer Res. 2012 Jul 15;72(14):3439-44
references.pmid: 22761338
references.citation: Cancer Immunol Immunother. 2009 Jun;58(6):855-65
references.pmid: 18841361
references.citation: Leukemia. 2006 Jan;20(1):29-34
references.pmid: 16281063
references.citation: Blood. 2007 Apr 1;109(7):2871-7
references.pmid: 17164341
references.citation: N Engl J Med. 2011 Aug 25;365(8):725-33
references.pmid: 21830940
references.citation: Blood. 2009 Oct 29;114(18):3909-16
references.pmid: 19710498
references.citation: Br J Haematol. 2003 Mar;120(6):1000-8
references.pmid: 12648070
references.citation: J Exp Med. 2006 Nov 27;203(12):2691-702
references.pmid: 17101732
references.citation: J Cell Mol Med. 2008 Jun;12(3):889-98
references.pmid: 18494931
references.citation: Anticancer Res. 2015 Mar;35(3):1251-61
references.pmid: 25750272
references.citation: J Clin Oncol. 2012 Jun 20;30(18):2204-10
references.pmid: 22585696
references.citation: N Engl J Med. 2012 Jun 28;366(26):2455-65
references.pmid: 22658128
references.citation: Leukemia. 2012 Mar;26(3):381-9
references.pmid: 21886171
references.citation: Blood. 2009 Oct 29;114(18):3793-802
references.pmid: 19724059
references.citation: Tissue Antigens. 2013 Apr;81(4):183-93
references.pmid: 23510414
references.citation: Front Immunol. 2013 Dec 31;4:496
references.pmid: 24427158
references.citation: Cancer. 2010 Dec 1;116(23):5420-31
references.pmid: 20672358
references.citation: Cell. 1992 Dec 24;71(7):1065-8
references.pmid: 1335362
references.citation: Blood. 2008 Feb 1;111(3):1060-6
references.pmid: 17962510
references.citation: Blood. 2004 Mar 1;103(5):1787-90
references.pmid: 14512311
references.citation: Blood. 2002 Mar 15;99(6):2146-53
references.pmid: 11877291
references.citation: J Exp Med. 1993 Jun 1;177(6):1675-80
references.pmid: 8496685
references.citation: Nat Rev Immunol. 2005 Aug;5(8):641-54
references.pmid: 16056256
references.citation: N Engl J Med. 2014 Oct 16;371(16):1507-17
references.pmid: 25317870
references.citation: Blood. 2004 Apr 15;103(8):3122-30
references.pmid: 15070694
references.citation: Blood. 1998 May 15;91(10):3671-80
references.pmid: 9573003
references.citation: N Engl J Med. 2009 Jul 30;361(5):478-88
references.pmid: 19641204
references.citation: PLoS One. 2012;7(1):e30264
references.pmid: 22279576
references.citation: Nat Med. 2007 Nov;13(11):1299-307
references.pmid: 17922010
references.citation: FASEB J. 1991 Aug;5(11):2516-22
references.pmid: 1907934
references.citation: Blood. 2013 May 16;121(20):4137-41
references.pmid: 23493782
references.citation: Cancer. 2005 Dec 15;104(12):2717-25
references.pmid: 16294345
references.citation: J Clin Oncol. 2011 Apr 1;29(10):1373-81
references.pmid: 21343549
references.citation: Prostate. 2009 Nov 1;69(15):1694-703
references.pmid: 19670224
references.citation: Cancer Immunol Res. 2014 Aug;2(8):725-31
references.pmid: 24878583
references.citation: Immunol Cell Biol. 2015 Mar;93(3):290-6
references.pmid: 25367186
references.citation: Haematologica. 2010 Mar;95(3):485-93
references.pmid: 19903675
references.citation: Blood. 2014 Jan 2;123(1):15-25
references.pmid: 24169824
references.citation: Front Immunol. 2015 Feb 04;6:36
references.pmid: 25699052
references.citation: Blood. 2013 Aug 1;122(5):749-58
references.pmid: 23733335
references.citation: J Clin Invest. 2010 Jul;120(7):2370-8
references.pmid: 20530875
references.citation: Cancer Immunol Immunother. 2009 Jul;58(7):1033-45
references.pmid: 19009291
references.citation: Blood. 2010 Oct 7;116(14):2484-93
references.pmid: 20570856
references.citation: Blood. 2009 Aug 20;114(8):1537-44
references.pmid: 19423728
references.citation: Immunol Rev. 2008 Aug;224:166-82
references.pmid: 18759926
references.citation: Clin Cancer Res. 2010 Oct 15;16(20):5067-78
references.pmid: 20736326
references.citation: Curr Pharm Des. 2004;10(8):893-8
references.pmid: 15032692
references.citation: J Exp Med. 1998 Jun 1;187(11):1885-92
references.pmid: 9607928
references.citation: Clin Exp Immunol. 2001 Dec;126(3):403-11
references.pmid: 11737054
references.citation: N Engl J Med. 2012 Jun 28;366(26):2443-54
references.pmid: 22658127
references.citation: Blood. 2012 May 17;119(20):4813-5
references.pmid: 22596173
references.citation: Cancer Immunol Immunother. 2009 Jul;58(7):1047-55
references.pmid: 19018534
references.citation: Haematologica. 2014 May;99(5):836-47
references.pmid: 24488563
references.citation: Haematologica. 2005 Jul;90(7):986-8
references.pmid: 15996941
references.citation: Blood. 2014 Feb 13;123(7):967-73
references.pmid: 24363403
references.citation: Int J Cancer. 2011 Sep 15;129(6):1373-81
references.pmid: 21105040
references.citation: Eur J Haematol. 2005 Dec;75(6):468-76
references.pmid: 16313258
references.citation: J Immunol. 1998 Jun 15;160(12):5729-34
references.pmid: 9637481
references.citation: Front Immunol. 2015 May 13;6:230
references.pmid: 26029215
references.citation: Haematologica. 2009 Sep;94(9):1266-73
references.pmid: 19734418
references.citation: Exp Hematol. 2001 Jun;29(6):709-19
references.pmid: 11378266
references.citation: Blood. 2009 Feb 12;113(7):1581-8
references.pmid: 18974373
references.citation: Immunol Rev. 2008 Apr;222:180-91
references.pmid: 18364002
references.citation: Clin Cancer Res. 2009 May 15;15(10):3325-32
references.pmid: 19417016
references.citation: Nat Rev Immunol. 2009 Mar;9(3):162-74
references.pmid: 19197294
references.citation: Nat Clin Pract Oncol. 2006 Dec;3(12):668-81
references.pmid: 17139318
references.citation: Blood. 2011 Mar 24;117(12):3353-62
references.pmid: 21278353
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):7095-101
references.pmid: 18981008
references.citation: Front Oncol. 2014 Dec 08;4:349
references.pmid: 25538893
references.citation: Immunol Rev. 2002 Oct;188:97-113
references.pmid: 12445284
references.citation: Exp Hematol. 2006 Jul;34(7):888-94
references.pmid: 16797416
references.citation: Nat Rev Cancer. 2009 Nov;9(11):798-809
references.pmid: 19851315
references.citation: Immunology. 2013 Jul;139(3):377-85
references.pmid: 23374145
references.citation: Lancet Oncol. 2014 Jun;15(7):e257-67
references.pmid: 24872109
references.citation: JAKSTAT. 2013 Jan 1;2(1):e23010
references.pmid: 24058791
references.citation: Blood. 2003 Jun 1;101(11):4485-91
references.pmid: 12576309
references.citation: Nat Rev Immunol. 2010 Jul;10(7):490-500
references.pmid: 20559327
references.citation: Blood. 2015 Jul 2;126(1):50-60
references.pmid: 26002964
references.citation: J Clin Oncol. 2010 Feb 1;28(4):562-9
references.pmid: 20026804
references.citation: J Clin Oncol. 2006 Aug 20;24(24):3895-903
references.pmid: 16921040
references.citation: Leukemia. 2014 Jun;28(6):1280-8
references.pmid: 24270737
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3921-6
references.pmid: 15001702
references.citation: Nature. 1995 Jun 29;375(6534):802-6
references.pmid: 7596415
references.citation: J Exp Med. 2002 Aug 19;196(4):459-68
references.pmid: 12186838
references.citation: JAMA. 2006 Dec 20;296(23):2823-31
references.pmid: 17179459
references.citation: Haematologica. 2009 Oct;94(10):1375-82
references.pmid: 19794082
references.citation: Cytotherapy. 2006;8(1):3-12
references.pmid: 16627340
references.citation: Blood. 2015 Apr 9;125(15):2386-96
references.pmid: 25710880
references.citation: PLoS One. 2012;7(2):e31046
references.pmid: 22383993
references.citation: Immunity. 2013 Jul 25;39(1):38-48
references.pmid: 23890062
references.citation: Cancer Res. 2009 Feb 1;69(3):1037-45
references.pmid: 19155305
references.citation: Leukemia. 1998 Jan;12(1):52-8
references.pmid: 9436920
references.citation: Nat Rev Cancer. 2004 May;4(5):371-80
references.pmid: 15122208
references.citation: Leuk Res Rep. 2013 Aug 28;2(2):70-4
references.pmid: 24371786
references.citation: J Clin Invest. 2010 Nov;120(11):3855-68
references.pmid: 20978352
references.citation: Blood. 2010 Apr 29;115(17):3520-30
references.pmid: 20197554
references.citation: Expert Rev Vaccines. 2006 Aug;5(4):467-72
references.pmid: 16989627
references.citation: Blood. 2011 Jan 13;117(2):608-17
references.pmid: 20935254
references.citation: Blood. 2014 Jun 19;123(25):3855-63
references.pmid: 24719405
references.citation: Leukemia. 2007 Feb;21(2):353-5
references.pmid: 17170728
references.citation: Semin Cancer Biol. 2003 Oct;13(5):317-23
references.pmid: 14708711
references.citation: Nat Rev Cancer. 2008 Feb;8(2):108-20
references.pmid: 18219306
references.citation: Cancer Cell. 2010 Dec 14;18(6):553-67
references.pmid: 21130701
references.citation: Front Immunol. 2013 Jan 03;3:388
references.pmid: 23316191
references.citation: Haematologica. 2011 Oct;96(10):1568-70
references.pmid: 21750085
references.citation: Cytotherapy. 2014 Nov;16(11):1453-1466
references.pmid: 24856895
references.citation: Curr Drug Targets. 2017;18(3):304-314
references.pmid: 25738295
references.citation: Blood. 2015 May 28;125(22):3393-400
references.pmid: 25833961
references.citation: Cancer. 2008 Oct 1;113(7):1596-604
references.pmid: 18720364
references.citation: Blood. 2009 Aug 20;114(8):1545-52
references.pmid: 19417208
references.citation: Blood. 1999 Jul 1;94(1):333-9
references.pmid: 10381530
references.citation: J Clin Oncol. 2010 Feb 1;28(4):556-61
references.pmid: 20026803
references.citation: J Clin Oncol. 2014 Feb 1;32(4):297-305
references.pmid: 24344214
references.citation: Blood. 2001 Jul 1;98(1):210-6
references.pmid: 11418482
references.citation: Blood. 2005 Nov 15;106(10):3666-72
references.pmid: 16046526
references.citation: Science. 1999 Jul 30;285(5428):727-9
references.pmid: 10426993
references.citation: J Clin Oncol. 2014 Apr 20;32(12):1242-8
references.pmid: 24663049
references.citation: Haematologica. 2008 Dec;93(12):1894-8
references.pmid: 19050070
references.citation: Br J Haematol. 2008 Sep;142(6):877-88
references.pmid: 18564358
references.citation: J Immunol. 2002 May 15;168(10):4914-9
references.pmid: 11994441
references.citation: Blood. 2007 Oct 1;110(7):2302-8
references.pmid: 17596541
references.citation: Haematologica. 2012 Mar;97(3):388-92
references.pmid: 22058207
references.citation: Haematologica. 2010 Dec;95(12):2022-30
references.pmid: 20801903
references.citation: J Clin Oncol. 2010 Feb 20;28(6):955-9
references.pmid: 20085940
references.citation: Leuk Res. 2009 Mar;33(3):490-4
references.pmid: 18639339
references.citation: Cancer Res. 2010 Apr 15;70(8):3052-61
references.pmid: 20388795
references.citation: Sci Transl Med. 2013 Feb 27;5(174):174ra27
references.pmid: 23447018
references.citation: Immunol Cell Biol. 2011 Mar;89(3):396-407
references.pmid: 21301477
references.citation: J Immunol. 1999 Jul 1;163(1):380-6
references.pmid: 10384139
references.citation: Leuk Lymphoma. 2007 Oct;48(10):1940-9
references.pmid: 17917962
references.citation: Lancet Oncol. 2015 Jan;16(1):57-66
references.pmid: 25524800
references.citation: Leuk Lymphoma. 2014 Sep;55(9):2120-4
references.pmid: 24283754
references.citation: Clin Cancer Res. 2012 Apr 1;18(7):2039-47
references.pmid: 22271879
references.citation: Clin Cancer Res. 2008 May 15;14(10):3044-51
references.pmid: 18483370
references.citation: Leukemia. 2012 May;26(5):934-42
references.pmid: 22116554
references.citation: Nat Med. 2002 Aug;8(8):793-800
references.pmid: 12091876
references.citation: J Exp Med. 1998 Nov 16;188(10):1849-57
references.pmid: 9815262
references.citation: Ann Hematol. 2005 May;84(5):287-97
references.pmid: 15592672
references.citation: Immunol Rev. 2010 Jul;236:219-42
references.pmid: 20636820
references.citation: Cancer Res. 2007 Jan 15;67(2):792-801
references.pmid: 17234791
references.citation: Leukemia. 2012 Mar;26(3):422-3
references.pmid: 21869837
references.citation: Transplant Proc. 2010 Oct;42(8):3293-6
references.pmid: 20970674
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13824-9
references.pmid: 20631300
references.citation: PLoS One. 2013 Oct 18;8(10):e76781
references.pmid: 24204673
references.citation: Cancer. 2008 Jan 15;112(2):407-15
references.pmid: 18058809
references.citation: Int J Hematol. 2011 Mar;93(3):274-280
references.pmid: 21380929
references.citation: Clin Cancer Res. 2014 Aug 1;20(15):4036-46
references.pmid: 24850840
references.citation: Sci Transl Med. 2010 Jul 21;2(41):41ra52
references.pmid: 20650872
references.citation: PLoS One. 2013;8(1):e55818
references.pmid: 23383287
references.citation: Br J Haematol. 2003 Feb;120(3):442-51
references.pmid: 12580958
references.citation: Blood. 2011 Nov 10;118(19):5084-95
references.pmid: 21881045
references.citation: Int J Cancer. 2015 Nov 1;137(9):2083-92
references.pmid: 25912930
references.citation: Nat Rev Immunol. 2006 Apr;6(4):295-307
references.pmid: 16557261
references.citation: Biol Blood Marrow Transplant. 2013 Jan;19(1):75-81
references.pmid: 22871557
references.citation: Transplantation. 2012 Apr 15;93(7):744-9
references.pmid: 22314337
references.citation: J Clin Oncol. 2012 Jul 20;30(21):2670-7
references.pmid: 22689805
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15825-30
references.pmid: 19717467
references.citation: Leukemia. 2013 Mar;27(3):725-8
references.pmid: 22828444
references.citation: Blood. 2010 Jan 7;115(1):107-21
references.pmid: 19887673
references.citation: Nat Rev Cancer. 2012 Mar 22;12(4):252-64
references.pmid: 22437870
references.citation: Blood. 2006 Nov 15;108(10):3271-9
references.pmid: 16882711
references.citation: J Immunol. 2004 Jan 15;172(2):989-99
references.pmid: 14707072
references.citation: J Clin Oncol. 2011 Jun 20;29(18):2493-8
references.pmid: 21576633
references.citation: Cancer Immunol Immunother. 2007 May;56(5):641-8
references.pmid: 16960692
references.citation: Blood. 2005 Apr 15;105(8):3051-7
references.pmid: 15632206
references.citation: Haematologica. 2013 Apr;98(4):591-6
references.pmid: 23242596
references.citation: Blood. 2012 Dec 20;120(26):5185-7
references.pmid: 23024237
references.citation: Bone Marrow Transplant. 2004 Jul;34(2):123-8
references.pmid: 15133487
references.citation: Cancer Immunol Immunother. 2013 Jan;62(1):39-49
references.pmid: 22733396
references.citation: J Clin Oncol. 2007 Sep 1;25(25):3884-91
references.pmid: 17679729
references.citation: Blood. 2014 Jul 31;124(5):750-60
references.pmid: 24850760
references.citation: Leukemia. 2013 Jul;27(7):1538-47
references.pmid: 23528871
references.citation: J Clin Oncol. 2012 Mar 1;30(7):742-50
references.pmid: 22291079
references.citation: Ann Hematol. 2005 Dec;84 Suppl 1:61-6
references.pmid: 16270213
references.citation: Bone Marrow Transplant. 2014 Feb;49(2):287-91
references.pmid: 23933760
references.citation: Biol Blood Marrow Transplant. 2013 Jul;19(7):1094-101
references.pmid: 23635453
references.citation: Blood. 2001 Dec 15;98(13):3750-6
references.pmid: 11739182
references.citation: J Exp Med. 1994 Sep 1;180(3):1107-13
references.pmid: 8064228
references.citation: Blood. 1995 Dec 1;86(11):4337-43
references.pmid: 7492795
references.citation: Immunol Today. 1999 Oct;20(10):469-73
references.pmid: 10500295
references.citation: Cancer Res. 2004 Aug 15;64(16):5839-49
references.pmid: 15313928
references.citation: Cancer. 2003 Mar 1;97(5):1234-41
references.pmid: 12599230
references.citation: Blood. 2003 Jan 1;101(1):202-9
references.pmid: 12393538
references.citation: Best Pract Res Clin Haematol. 2008 Sep;21(3):437-53
references.pmid: 18790448
references.citation: Haematologica. 2010 Jan;95(1):126-34
references.pmid: 19679884
references.citation: J Immunol. 2012 Dec 1;189(11):5476-84
references.pmid: 23105141
references.citation: N Engl J Med. 2013 Apr 18;368(16):1509-1518
references.pmid: 23527958
references.citation: Blood. 2010 Jul 8;116(1):129-39
references.pmid: 20424188
references.citation: Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):157-161
references.pmid: 30713125
references.citation: Cancer Immunol Immunother. 2010 Dec;59(12):1839-49
references.pmid: 20814675
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2995-3000
references.pmid: 11867742
references.citation: Nat Rev Clin Oncol. 2009 Sep;6(9):503-5
references.pmid: 19707241
references.citation: Cancer Biol Ther. 2008 May;7(5):622-7
references.pmid: 18756622
references.citation: Cancer. 2015 Feb 15;121(4):556-61
references.pmid: 25336333
references.citation: Blood. 2007 Apr 1;109(7):2781-90
references.pmid: 17179232
references.citation: Leukemia. 2015 May;29(5):1143-52
references.pmid: 25371177
references.citation: J Clin Invest. 2008 Jul;118(7):2427-37
references.pmid: 18551193
references.citation: Nat Med. 2003 Oct;9(10):1269-74
references.pmid: 14502282